UTHR — United Therapeutics Share News
0.000.00%
Last trade - 00:00- $25.46bn
- $22.80bn
- $3.18bn
U.S. RESEARCH ROUNDUP- IQVIA Holdings, Reliance, United Therapeutics
U.S. STOCKS ON THE MOVE-Cytokinetics, Air Lease Corp, Lyft Inc
United Therapeutics hits record high after positive lung disease study
U.S. STOCKS ON THE MOVE-United Therapeutics, Signet Jewelers, Arrowhead
United Therapeutics shares surge as lung disease drug meets main study goal (updated)
U.S. STOCKS ON THE MOVE-PepsiCo, Ionis Pharma, United Therapeutics
United Therapeutics shares surge on successful late-stage lung disease study
United Therapeutics soars after lung disease drug meets main study goal
Brief: United Therapeutics Corporation Announces Teton-2 Pivotal Study Of Tyvaso® Meets Primary Endpoint For The Treatment Of Idiopathic Pulmonary Fibrosis
U.S. RESEARCH ROUNDUP-Home Depot, News, Premier
Brief: United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
United Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
United Therapeutics' Q2 revenue misses estimates
Brief: United Therapeutics And Intermountain Health Announce The First Patient Treated With External Liver Support Using A Bioengineered Liver
Brief: United Therapeutics Corporation Concludes Enrollment Of The Advance Outcomes Study Of Ralinepag
Insmed hits more than two-decade high as rare lung disease drug succeeds in trial
Insmed soars as rare lung disease drug succeeds in mid-stage trial; drags rivals down
Brief: Liquidia Says New Litigation Filed Against Co In U.S.
Liquidia falls after United Therapeutics files new patent suit over inhaled drug